At the intersection of mobility, transport, and the drug trade: Identifying ‘drug mobilities’
Why is drug driving detected so frequently in Norway?
Working group B2: Prevention and Rehabilitation
Working group A1: Legal Aspects
Practical experience in the field of control
Working group B1: Prevalence, Epidemiology, Risk assessment
Working group A2: Issues of Law Enforcement
Licit drugs and driving: prevention by informing patients, physicians and pharmacists
Drug recognition in road traffic training: a programme for police officers in Germany
Amendment of the Federal Road Traffic Act
The United States experience in developing and validating DRE/DEC in the field
The Belgian legislation on Drug Driving